Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
72.81
-1.73 (-2.32%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $721.39 million as of August 28, 2026. Its market cap has increased by 132.70% in one year.
Market Cap
721.39M
Enterprise Value
499.88M
1-Year Change
132.70%
Ranking
Category
Stock Price
$72.81
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $721.39M, an increase of 1,626.51%. That is a compound annual growth rate of 67.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 721.39M | 15.02% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aura Biosciences | 802.68M |
| Oculis Holding AG | 785.85M |
| Shattuck Labs | 785.84M |
| Monopar Therapeutics | 768.41M |
| Crescent Biopharma | 767.85M |
| Neurogene | 767.44M |
| Obsidian Therapeutics | 750.85M |
| BridgeBio Oncology Therapeutics | 737.20M |